About Nativis
Nativis is a company based in Seattle (United States) founded in 2002. Nativis has raised $28.43 million across 9 funding rounds. The company has 13 employees as of December 31, 2010. Nativis operates in a competitive market with competitors including ChemoTech, IGEA, RanD and Papyrus Therapeutics, among others.
- Headquarter Seattle, United States
- Employees 13 as on 31 Dec, 2010
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.43 M (USD)
in 9 rounds
-
Latest Funding Round
$4.12 M (USD), Series B
Nov 14, 2018
-
Investors
Not available
-
Employee Count
13
as on Dec 31, 2010
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nativis
Nativis has successfully raised a total of $28.43M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $4.12 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Nativis
Investment portfolio details for Nativis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nativis
Detailed financials for Nativis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nativis Comparisons
Peer comparison for Nativis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nativis
Nativis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChemoTech, IGEA, RanD and Papyrus Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of electroporation devices for the treatment of cancer
|
|
| Locked | Locked | Locked |
Orthopedic medical devices to promote reparative osteogenesis and joint protection
|
|
| Locked | Locked | Locked |
Medical devices for surgical oncology are developed using extracorporeal technologies.
|
|
| Locked | Locked | Locked |
Develops therapies for tumor suppression in various cancers through scientific research.
|
Detailed competitors of Nativis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nativis
Complete news archive for Nativis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nativis
Nativis was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Nativis is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Nativis is a funded company, having raised a total of $28.43M across 9 funding rounds to date.
As of Dec 31, 2010, the latest employee count at Nativis is 13.
Nativis was founded in 2002 in Seattle, United States, and operates in the medical device sector focused on oncology and related conditions. A therapeutic device is developed that employs ultra-low radio frequency energy to target metabolic pathways at molecular and genetic levels. Treatments are provided for brain cancer, lung cancer, other cancers, inflammatory diseases, and chronic pain, with operations centered in the United States.